Smoking and Substance Misuse - PowerPoint PPT Presentation

1 / 33
About This Presentation
Title:

Smoking and Substance Misuse

Description:

Smoking and Substance Misuse Slides by Ann McNeill, Luke Mitcheson and Gay Sutherland Institute of Psychiatry, KCL ... – PowerPoint PPT presentation

Number of Views:140
Avg rating:3.0/5.0
Slides: 34
Provided by: AnnMc69
Category:

less

Transcript and Presenter's Notes

Title: Smoking and Substance Misuse


1
Smoking and Substance Misuse
  • Slides by Ann McNeill, Luke Mitcheson and Gay
    Sutherland
  • Institute of Psychiatry, KCL

2
Summary
  • Relationship between smoking and substance misuse
    and treatment
  • Local audits
  • NICE guidance
  • Next steps?

3
  • 3 million smokers in UK with a mental health
    disorder
  • No change in prevalence in last 20-30 yrs
  • Moral imperative
  • Radical changes needed

4
Smoking Prevalence ()
Note General Population includes all categories
of mental illness
5
Healthcare Staff Culture!
  • Psychiatrists have higher smoking rates than
    other medics and are less likely to treat
    nicotine addiction!
  • Believe MI smokers do not want to quit
  • Believe they can not quit
  • Believe quitting would negatively affect their
    mental state

Wrong!
6
(No Transcript)
7
Smoking and substance misuse
  • Largest cause of preventable death, disease
    health inequalities in the UK
  • High smoking prevalence previously demonstrated
    in substance misusers and interrelationship e.g.
  • Smokers subjective symptoms of methadone
    inadequacy
  • Smoking impedes cognitive recovery after alcohol
    abstinence
  • Smokers require higher doses of some
    benozodiapines/opiates
  • Tobacco/cannabis users made fewer attempts to
    quit and less likely to successfully quit than
    tobacco-only smokers

8
Mortality and morbidity
  • Smoking may be responsible for much of the
    increased mortality of substance misusers
    compared with general pop. Eg.
  • Cohort study of 845 substance misusers in
    Minnesota
  • 222 died during study
  • 214 with death certificates 51
    tobacco-related death, gt than proportion from
    alcohol other drug-related causes (Hurt et al,
    1996)
  • Tobacco alcohol use multiplies risk of
    developing cancers of upper respiratory
    digestive tracts (Kalman et al, 2010 Baca
    Yahne, 2009)

9
NICE recommendations include
  • Identifying people who smoke and offering and
    arranging support
  • Implementing a comprehensive smoke-free policy
    including the grounds
  • Support for staff who smoke
  • Training for staff

10
Treatment
  • Smoking cessation does NOT impact negatively on
    success of abstinence from other substances may
    improve outcomes continued nicotine dependence
    may be a risk factor for relapse
  • Meta-analysis of 19 RCTs of smoking-cessation
    interventions for people in substance misuse
    treatment and in recovery showed concurrent
    treatment of smoking resulted in a 25 increased
    likelihood of long-term abstinence from alcohol
    and illicit drugs
  • Khara Okoli, 2011 Burling et al, 2001 Kalman
    et al, 2010 Baca Yahne 2009 Williams
    Ziedonis, 2004 Prochaska et al, 2004 Stapleton
    et al, 2009 Goulay et al, 1994 Moore Budney,
    2001 Prochaska et al, 2004

11
Treatment
  • Smoking cessation programmes exclusively
    addressing tobacco less effective for cannabis
    users

12
SLaM audits
  • Audit of all computerised client records across
    SLaM since 2008 for smoking status recording,
    prevalence and offer of support
  • Audit of addiction wards and community services
    in SlaM in 2012-3

13
Diagnosis N Smoking Status Recorded Smokers 20-22 General Pop. Received advice to quit Received referral to smoking service
Depression F32/33 26,828 12 (3,221) 34 (1,103) 72 (796) 13 (141)
Personality Disorders F60/61 4,621 22 (1,023) 64 (659) 76 (501) 17 (115)
Serious Mental Illness F20/25/31 15,954 33 (5,359) 54 (2,909) 83 (2,439) 22 (656)
Opiate use 6,491 26 (1,700) 89 (1,524) 71 (1,088) 7.4 (113)
Alcohol use 11,158 15 (1,730) 77 (1,335) 67 (906) 7.4 (129)
14
Diagnosis N Smoking Status Recorded Smokers 20-22 General Pop. Received advice to quit Received referral to smoking service
Depression F32/33 26,828 12 (3,221) 34 (1,103) 72 (796) 13 (141)
Personality Disorders F60/61 4,621 22 (1,023) 64 (659) 76 (501) 17 (115)
Serious Mental Illness F20/25/31 15,954 33 (5,359) 54 (2,909) 83 (2,439) 22 (656)
Opiate use 6,491 26 (1,700) 89 (1,524) 71 (1,088) 7.4 (113)
Alcohol use 11,158 15 (1,730) 77 (1,335) 67 (906) 7.4 (129)
15
Diagnosis N Smoking Status Recorded Smokers 20-22 General Pop. Received advice to quit Received referral to smoking service
Depression F32/33 26,828 12 (3,221) 34 (1,103) 72 (796) 13 (141)
Personality Disorders F60/61 4,621 22 (1,023) 64 (659) 76 (501) 17 (115)
Serious Mental Illness F20/25/31 15,954 33 (5,359) 54 (2,909) 83 (2,439) 22 (656)
Opiate use 6,491 26 (1,700) 89 (1,524) 71 (1,088) 7.4 (113)
Alcohol use 11,158 15 (1,730) 77 (1,335) 67 (906) 7.4 (129)
16
SLaM audits
  • Audit of all computerised client records across
    SLaM since 2008 for smoking status recording,
    prevalence and offer of support
  • Audit of addiction wards and community services
    in SlaM in 2012-3

17
Smoking Audit Method
  • Questionnaire survey conducted across Addiction
    services in or connected to SLaM
  • (Blackfriars, Lantern Hall, Beresford Project,
    Lorraine Hewitt House, AAU, Clouds House, and Ley
    Community)
  • Staff and client questionnaires to measure
  • smoking behaviour
  • motivation to quit
  • treatment provision
  • attitudes towards nicotine dependence treatment
  • 97 (n145) and 85 (n163) response rates for
    staff and clients respectively.

18
Key Findings 1. High smoking prevalence
  Staff Clients
Ever smoked 70 (n 102) 94 (n 154)
Currently smoking 45 (n 65) 88 (n 144)
General Pop. 20
19
(2) Motivated client group
  • 81 of clients who smoked wanted to give up
  • 23 wanted to in next 3 months
  • 46 wanted to talk to someone about reducing
    harmfulness of their smoking 21 did not know
  • 53 wanted advice on stopping abruptly
  • 77 wanted advice on gradually reducing no. of
    cigs smoked
  • 87 wanted info on NRT
  • gt2/3rd of clients did not know enough about
    varenicline (Champix) or bupropion (Zyban) to
    express any interest

20
3. A Lack of Treatment Provision
  • Only 15 clients who smoked had been offered
    support during current treatment episode
  • 56 had never been offered support

Huge unmet clinical challenge
21
4. Staff and Client Attitudes
  • Staff rated nic add. treatment significantly less
    important than treatment of other substances
  • 53 staff thought addressing smoking should be
    put off until late or after a clients primary
    addiction treatment
  • Only 29 thought it should be addressed early in
    treatment
  • But nearly half of clients thought it should be
    addressed early in treatment
  • Staff confidence rating for helping client who
    wanted to quit 7 (10 point scale) but varied
    considerably

22
Steps being taken
  • Assessing evidence on treatment of smoking and
    illicit drugs
  • Improving recording and referrals in line with
    new SLaM systems
  • Reorientation of the Maudsley Specialist Smokers
    Clinic

23
Conclusions
  • Strong relationship between smoking and use of
    other substances
  • Motivation to stop is apparent but not being
    addressed
  • Need to treat substances concurrently (e.g.
    Becker et al, 2013)
  • Staff who smoke more likely to question
    importance of tobacco treatment, so no. of staff
    smoking is a concern for their own and patients
    health
  • Introducing mandatory training and care pathways
    within SLaM to address concerns and also NICE
    guidance

24
(No Transcript)
25
Harm Reduction for Smoking?
  • Nicotine is largely why people smoke
  • But its the other smoke constituents (CO, tar
    etc) that cause the death and disease

26
Rationale for Harm Reduction Nicotine Harm
Continuum
E-cigs?
NRT
QUIT!
Most Dangerous
Least Dangerous
27
Whats Needed?
  • Develop clinical pathway to address the unmet
    clinical need
  • Mandatory recording of smoking status
  • Development of routinely provided support which
    should be documented in case notes
  • Signpost specialist services
  • NRT for withdrawal relief available to
    in-patients

28
Clinically Significant Interactions with Tobacco
  • Antidepressants
  • Amitriptyline
  • Nortriptyline
  • Imipramine
  • Clomipramine
  • Fluvoxamine
  • Trazodone
  • Antipsychotics
  • Clozapine
  • Fluphenazine
  • Haloperidol
  • Olanzapine
  • Chlorpromazine

29
Other Clinically Significant Interactions with
Tobacco
  • Heparin
  • Insulin
  • Warfarin
  • Theophylline
  • Propranolol
  • Tacrine
  • Acetaminophen
  • Caffeine

30
Recording and Monitoring
31
Whats needed?
  • Develop clinical pathway to address the unmet
    clinical need
  • Staff training
  • Support for staff smokers
  • We are doing some qualitative research with staff
    to explore high levels of occasional smoking
    further

32
What Can be Done Locally?
  • Promote discussion around how your service can
    encourage and support smoking cessation
  • Identify a smoking champion on the ward/service
  • Routinely ask and record clients smoking status
    and motivation to quit
  • Inform clients about pharmacological and
    behavioural support available as part of standard
    care and consider harm reduction for smokers who
    cannot or will not stop
  • Identify where clients and staff can get support
    and clearly signpost this
  • Encourage staff to complete relevant training
    (mandatory?)

33
Acknowledgements
  • Camilla Cookson
  • All colleagues in the services in SLaM who
    supported the audit
  • Karolina Bogdanowicz
  • Prof John Strang
  • Dr Elena Ratschen
Write a Comment
User Comments (0)
About PowerShow.com